APO Research
Talk to an analyst

APO RESEARCH · REPORT

Growth & Differentiation Factor 8

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Growth & Differentiation Factor 8 Market Analysis and Forecast 2026-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchGrowth & Differentiation Factor 8 Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Growth & Differentiation Factor 8 Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Growth & Differentiation Factor 8 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Growth & Differentiation Factor 8 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Growth & Differentiation Factor 8 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Growth & Differentiation Factor 8 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Growth & Differentiation Factor 8 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Growth & Differentiation Factor 8 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Growth & Differentiation Factor 8 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Growth & Differentiation Factor 8 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Growth & Differentiation Factor 8 include Eli Lilly and Company, Pfizer Inc., Bristol-Myers Squibb Company, Scholar Rock, Inc., Sarepta Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., Milo Biotechnology LLC, Atara Biotherapeutics, Inc. and Acceleron Pharma, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Growth & Differentiation Factor 8, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Growth & Differentiation Factor 8, also provides the revenue of main regions and countries. Of the upcoming market potential for Growth & Differentiation Factor 8, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Growth & Differentiation Factor 8 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Growth & Differentiation Factor 8 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Growth & Differentiation Factor 8 revenue, projected growth trends, production technology, application and end-user industry.

Growth & Differentiation Factor 8 Segment by Company

Eli Lilly and Company

Pfizer Inc.

Bristol-Myers Squibb Company

Scholar Rock, Inc.

Sarepta Therapeutics, Inc.

Regeneron Pharmaceuticals, Inc.

Milo Biotechnology LLC

Atara Biotherapeutics, Inc.

Acceleron Pharma, Inc.

Growth & Differentiation Factor 8 Segment by Type

ACE-2494

ACE-2798

BMS-986089

OSX-200

SRK-015

Others

Growth & Differentiation Factor 8 Segment by Application

Fibrosis

Sickle Cell Disease

Myelofibrosis

Becker Muscular Dystrophy

Others

Growth & Differentiation Factor 8 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Growth & Differentiation Factor 8 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Growth & Differentiation Factor 8 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Growth & Differentiation Factor 8.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Growth & Differentiation Factor 8 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Growth & Differentiation Factor 8 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Growth & Differentiation Factor 8 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Growth & Differentiation Factor 8 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ACE-2494 Major Player Table 3. ACE-2798 Major Player Table 4. BMS-986089 Major Player Table 5. OSX-200 Major Player Table 6. SRK-015 Major Player Table 7. Others Major Player Table 8. Global Growth & Differentiation Factor 8 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Fibrosis Major Player Table 10. Sickle Cell Disease Major Player Table 11. Myelofibrosis Major Player Table 12. Becker Muscular Dystrophy Major Player Table 13. Others Major Player Table 14. Growth & Differentiation Factor 8 Industry Trends Table 15. Growth & Differentiation Factor 8 Industry Drivers Table 16. Growth & Differentiation Factor 8 Industry Opportunities and Challenges Table 17. Growth & Differentiation Factor 8 Industry Restraints Table 18. Global Growth & Differentiation Factor 8 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global Growth & Differentiation Factor 8 Market Size by Region (2021-2026) & (US$ Million) Table 20. Global Growth & Differentiation Factor 8 Market Share by Region (2021-2026) Table 21. Global Growth & Differentiation Factor 8 Market Size by Region (2027-2032) & (US$ Million) Table 22. Global Growth & Differentiation Factor 8 Market Share by Region (2027-2032) Table 23. Global Growth & Differentiation Factor 8 Revenue by Players (US$ Million) & (2021-2026) Table 24. Global Growth & Differentiation Factor 8 Revenue Market Share by Players (2021-2026) Table 25. Global Growth & Differentiation Factor 8 Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global Growth & Differentiation Factor 8 Key Players Headquarters & Area Served Table 27. Global Growth & Differentiation Factor 8 Players, Product Type & Application Table 28. Global Growth & Differentiation Factor 8 Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global Growth & Differentiation Factor 8 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global Growth & Differentiation Factor 8 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Growth & Differentiation Factor 8 Revenue by Type (2021-2026) & (US$ Million) Table 33. Global Growth & Differentiation Factor 8 Revenue by Type (2027-2032) & (US$ Million) Table 34. Global Growth & Differentiation Factor 8 Revenue Market Share by Type (2021-2026) Table 35. Global Growth & Differentiation Factor 8 Revenue Market Share by Type (2027-2032) Table 36. Global Growth & Differentiation Factor 8 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Growth & Differentiation Factor 8 Revenue by Application (2021-2026) & (US$ Million) Table 38. Global Growth & Differentiation Factor 8 Revenue by Application (2027-2032) & (US$ Million) Table 39. Global Growth & Differentiation Factor 8 Revenue Market Share by Application (2021-2026) Table 40. Global Growth & Differentiation Factor 8 Revenue Market Share by Application (2027-2032) Table 41. Eli Lilly and Company Company Information Table 42. Eli Lilly and Company Business Overview Table 43. Eli Lilly and Company Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Eli Lilly and Company Growth & Differentiation Factor 8 Product Portfolio Table 45. Eli Lilly and Company Recent Development Table 46. Pfizer Inc. Company Information Table 47. Pfizer Inc. Business Overview Table 48. Pfizer Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Pfizer Inc. Growth & Differentiation Factor 8 Product Portfolio Table 50. Pfizer Inc. Recent Development Table 51. Bristol-Myers Squibb Company Company Information Table 52. Bristol-Myers Squibb Company Business Overview Table 53. Bristol-Myers Squibb Company Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bristol-Myers Squibb Company Growth & Differentiation Factor 8 Product Portfolio Table 55. Bristol-Myers Squibb Company Recent Development Table 56. Scholar Rock, Inc. Company Information Table 57. Scholar Rock, Inc. Business Overview Table 58. Scholar Rock, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Scholar Rock, Inc. Growth & Differentiation Factor 8 Product Portfolio Table 60. Scholar Rock, Inc. Recent Development Table 61. Sarepta Therapeutics, Inc. Company Information Table 62. Sarepta Therapeutics, Inc. Business Overview Table 63. Sarepta Therapeutics, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sarepta Therapeutics, Inc. Growth & Differentiation Factor 8 Product Portfolio Table 65. Sarepta Therapeutics, Inc. Recent Development Table 66. Regeneron Pharmaceuticals, Inc. Company Information Table 67. Regeneron Pharmaceuticals, Inc. Business Overview Table 68. Regeneron Pharmaceuticals, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Regeneron Pharmaceuticals, Inc. Growth & Differentiation Factor 8 Product Portfolio Table 70. Regeneron Pharmaceuticals, Inc. Recent Development Table 71. Milo Biotechnology LLC Company Information Table 72. Milo Biotechnology LLC Business Overview Table 73. Milo Biotechnology LLC Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Milo Biotechnology LLC Growth & Differentiation Factor 8 Product Portfolio Table 75. Milo Biotechnology LLC Recent Development Table 76. Atara Biotherapeutics, Inc. Company Information Table 77. Atara Biotherapeutics, Inc. Business Overview Table 78. Atara Biotherapeutics, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Atara Biotherapeutics, Inc. Growth & Differentiation Factor 8 Product Portfolio Table 80. Atara Biotherapeutics, Inc. Recent Development Table 81. Acceleron Pharma, Inc. Company Information Table 82. Acceleron Pharma, Inc. Business Overview Table 83. Acceleron Pharma, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Acceleron Pharma, Inc. Growth & Differentiation Factor 8 Product Portfolio Table 85. Acceleron Pharma, Inc. Recent Development Table 86. North America Growth & Differentiation Factor 8 Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Growth & Differentiation Factor 8 Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Growth & Differentiation Factor 8 Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Growth & Differentiation Factor 8 Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Growth & Differentiation Factor 8 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Growth & Differentiation Factor 8 Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Growth & Differentiation Factor 8 Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Growth & Differentiation Factor 8 Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Growth & Differentiation Factor 8 Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Growth & Differentiation Factor 8 Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Growth & Differentiation Factor 8 Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Growth & Differentiation Factor 8 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Growth & Differentiation Factor 8 Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Growth & Differentiation Factor 8 Revenue by Country (US$ Million) & (2027-2032) Table 100. China Growth & Differentiation Factor 8 Revenue by Type (2021-2026) & (US$ Million) Table 101. China Growth & Differentiation Factor 8 Revenue by Type (2027-2032) & (US$ Million) Table 102. China Growth & Differentiation Factor 8 Revenue by Application (2021-2026) & (US$ Million) Table 103. China Growth & Differentiation Factor 8 Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Growth & Differentiation Factor 8 Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Growth & Differentiation Factor 8 Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Growth & Differentiation Factor 8 Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Growth & Differentiation Factor 8 Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Growth & Differentiation Factor 8 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Growth & Differentiation Factor 8 Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Growth & Differentiation Factor 8 Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Growth & Differentiation Factor 8 Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Growth & Differentiation Factor 8 Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Growth & Differentiation Factor 8 Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Growth & Differentiation Factor 8 Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Growth & Differentiation Factor 8 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Growth & Differentiation Factor 8 Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Growth & Differentiation Factor 8 Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Growth & Differentiation Factor 8 Image Figure 2. Global Growth & Differentiation Factor 8 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Growth & Differentiation Factor 8 Market Size Share 2021 VS 2025 VS 2032 Figure 4. ACE-2494 Image Figure 5. ACE-2798 Image Figure 6. BMS-986089 Image Figure 7. OSX-200 Image Figure 8. SRK-015 Image Figure 9. Others Image Figure 10. Global Growth & Differentiation Factor 8 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Growth & Differentiation Factor 8 Market Size Share 2021 VS 2025 VS 2032 Figure 12. Fibrosis Image Figure 13. Sickle Cell Disease Image Figure 14. Myelofibrosis Image Figure 15. Becker Muscular Dystrophy Image Figure 16. Others Image Figure 17. Global Growth & Differentiation Factor 8 Market Size (US$ Million) & (2021-2032) Figure 18. Global Growth & Differentiation Factor 8 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Growth & Differentiation Factor 8 Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global Growth & Differentiation Factor 8 Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Growth & Differentiation Factor 8 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Growth & Differentiation Factor 8 Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Growth & Differentiation Factor 8 Revenue Market Share by Type (2021-2032) Figure 25. Global Growth & Differentiation Factor 8 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Growth & Differentiation Factor 8 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global Growth & Differentiation Factor 8 Revenue Market Share by Application (2021-2032) Figure 28. North America Growth & Differentiation Factor 8 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032) Figure 30. North America Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032) Figure 31. North America Growth & Differentiation Factor 8 Revenue Share by Country (2021-2032) Figure 32. United States Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe Growth & Differentiation Factor 8 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032) Figure 37. Europe Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032) Figure 38. Europe Growth & Differentiation Factor 8 Revenue Share by Country (2021-2032) Figure 39. Germany Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China Growth & Differentiation Factor 8 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032) Figure 49. China Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032) Figure 50. Asia Growth & Differentiation Factor 8 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032) Figure 52. Asia Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032) Figure 53. Asia Growth & Differentiation Factor 8 Revenue Share by Region (2021-2032) Figure 54. Japan Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA Growth & Differentiation Factor 8 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032) Figure 62. SAMEA Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032) Figure 63. SAMEA Growth & Differentiation Factor 8 Revenue Share by Country (2021-2032) Figure 64. Brazil Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt Growth & Differentiation Factor 8 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • ACE-2494
  • ACE-2798
  • BMS-986089
  • OSX-200
  • SRK-015
  • Others
Applications
  • Fibrosis
  • Sickle Cell Disease
  • Myelofibrosis
  • Becker Muscular Dystrophy
  • Others
Companies covered
  • Eli Lilly and Company
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Scholar Rock, Inc.
  • Sarepta Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Milo Biotechnology LLC
  • Atara Biotherapeutics, Inc.
  • Acceleron Pharma, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Growth & Differentiation Factor 8 Market by Type
  3. 1.2.1 Global Growth & Differentiation Factor 8 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ACE-2494
  5. 1.2.3 ACE-2798
  6. 1.2.4 BMS-986089
  7. 1.2.5 OSX-200
  8. 1.2.6 SRK-015
  9. 1.2.7 Others
  10. 1.3 Growth & Differentiation Factor 8 Market by Application
  11. 1.3.1 Global Growth & Differentiation Factor 8 Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Fibrosis
  13. 1.3.3 Sickle Cell Disease
  14. 1.3.4 Myelofibrosis
  15. 1.3.5 Becker Muscular Dystrophy
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Growth & Differentiation Factor 8 Market Dynamics
  1. 2.1 Growth & Differentiation Factor 8 Industry Trends
  2. 2.2 Growth & Differentiation Factor 8 Industry Drivers
  3. 2.3 Growth & Differentiation Factor 8 Industry Opportunities and Challenges
  4. 2.4 Growth & Differentiation Factor 8 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Growth & Differentiation Factor 8 Market Perspective (2021-2032)
  2. 3.2 Global Growth & Differentiation Factor 8 Growth Trends by Region
  3. 3.2.1 Global Growth & Differentiation Factor 8 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Growth & Differentiation Factor 8 Market Size by Region (2021-2026)
  5. 3.2.3 Global Growth & Differentiation Factor 8 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Growth & Differentiation Factor 8 Revenue by Players
  2. 4.1.1 Global Growth & Differentiation Factor 8 Revenue by Players (2021-2026)
  3. 4.1.2 Global Growth & Differentiation Factor 8 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Growth & Differentiation Factor 8 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Growth & Differentiation Factor 8 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Growth & Differentiation Factor 8 Key Players Headquarters & Area Served
  7. 4.4 Global Growth & Differentiation Factor 8 Players, Product Type & Application
  8. 4.5 Global Growth & Differentiation Factor 8 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Growth & Differentiation Factor 8 Market CR5 and HHI
  11. 4.6.3 2025 Growth & Differentiation Factor 8 Tier 1, Tier 2, and Tier 3
5 Growth & Differentiation Factor 8 Market Size by Type
  1. 5.1 Global Growth & Differentiation Factor 8 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Growth & Differentiation Factor 8 Revenue by Type (2021-2032)
  3. 5.3 Global Growth & Differentiation Factor 8 Revenue Market Share by Type (2021-2032)
6 Growth & Differentiation Factor 8 Market Size by Application
  1. 6.1 Global Growth & Differentiation Factor 8 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Growth & Differentiation Factor 8 Revenue by Application (2021-2032)
  3. 6.3 Global Growth & Differentiation Factor 8 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eli Lilly and Company
  2. 7.1.1 Eli Lilly and Company Company Information
  3. 7.1.2 Eli Lilly and Company Business Overview
  4. 7.1.3 Eli Lilly and Company Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eli Lilly and Company Growth & Differentiation Factor 8 Product Portfolio
  6. 7.1.5 Eli Lilly and Company Recent Developments
  7. 7.2 Pfizer Inc.
  8. 7.2.1 Pfizer Inc. Company Information
  9. 7.2.2 Pfizer Inc. Business Overview
  10. 7.2.3 Pfizer Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc. Growth & Differentiation Factor 8 Product Portfolio
  12. 7.2.5 Pfizer Inc. Recent Developments
  13. 7.3 Bristol-Myers Squibb Company
  14. 7.3.1 Bristol-Myers Squibb Company Company Information
  15. 7.3.2 Bristol-Myers Squibb Company Business Overview
  16. 7.3.3 Bristol-Myers Squibb Company Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bristol-Myers Squibb Company Growth & Differentiation Factor 8 Product Portfolio
  18. 7.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 7.4 Scholar Rock, Inc.
  20. 7.4.1 Scholar Rock, Inc. Company Information
  21. 7.4.2 Scholar Rock, Inc. Business Overview
  22. 7.4.3 Scholar Rock, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Scholar Rock, Inc. Growth & Differentiation Factor 8 Product Portfolio
  24. 7.4.5 Scholar Rock, Inc. Recent Developments
  25. 7.5 Sarepta Therapeutics, Inc.
  26. 7.5.1 Sarepta Therapeutics, Inc. Company Information
  27. 7.5.2 Sarepta Therapeutics, Inc. Business Overview
  28. 7.5.3 Sarepta Therapeutics, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sarepta Therapeutics, Inc. Growth & Differentiation Factor 8 Product Portfolio
  30. 7.5.5 Sarepta Therapeutics, Inc. Recent Developments
  31. 7.6 Regeneron Pharmaceuticals, Inc.
  32. 7.6.1 Regeneron Pharmaceuticals, Inc. Company Information
  33. 7.6.2 Regeneron Pharmaceuticals, Inc. Business Overview
  34. 7.6.3 Regeneron Pharmaceuticals, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Regeneron Pharmaceuticals, Inc. Growth & Differentiation Factor 8 Product Portfolio
  36. 7.6.5 Regeneron Pharmaceuticals, Inc. Recent Developments
  37. 7.7 Milo Biotechnology LLC
  38. 7.7.1 Milo Biotechnology LLC Company Information
  39. 7.7.2 Milo Biotechnology LLC Business Overview
  40. 7.7.3 Milo Biotechnology LLC Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Milo Biotechnology LLC Growth & Differentiation Factor 8 Product Portfolio
  42. 7.7.5 Milo Biotechnology LLC Recent Developments
  43. 7.8 Atara Biotherapeutics, Inc.
  44. 7.8.1 Atara Biotherapeutics, Inc. Company Information
  45. 7.8.2 Atara Biotherapeutics, Inc. Business Overview
  46. 7.8.3 Atara Biotherapeutics, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Atara Biotherapeutics, Inc. Growth & Differentiation Factor 8 Product Portfolio
  48. 7.8.5 Atara Biotherapeutics, Inc. Recent Developments
  49. 7.9 Acceleron Pharma, Inc.
  50. 7.9.1 Acceleron Pharma, Inc. Company Information
  51. 7.9.2 Acceleron Pharma, Inc. Business Overview
  52. 7.9.3 Acceleron Pharma, Inc. Growth & Differentiation Factor 8 Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Acceleron Pharma, Inc. Growth & Differentiation Factor 8 Product Portfolio
  54. 7.9.5 Acceleron Pharma, Inc. Recent Developments
8 North America
  1. 8.1 North America Growth & Differentiation Factor 8 Revenue (2021-2032)
  2. 8.2 North America Growth & Differentiation Factor 8 Revenue by Type (2021-2032)
  3. 8.2.1 North America Growth & Differentiation Factor 8 Revenue by Type (2021-2026)
  4. 8.2.2 North America Growth & Differentiation Factor 8 Revenue by Type (2027-2032)
  5. 8.3 North America Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032)
  6. 8.4 North America Growth & Differentiation Factor 8 Revenue by Application (2021-2032)
  7. 8.4.1 North America Growth & Differentiation Factor 8 Revenue by Application (2021-2026)
  8. 8.4.2 North America Growth & Differentiation Factor 8 Revenue by Application (2027-2032)
  9. 8.5 North America Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032)
  10. 8.6 North America Growth & Differentiation Factor 8 Revenue by Country
  11. 8.6.1 North America Growth & Differentiation Factor 8 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Growth & Differentiation Factor 8 Revenue by Country (2021-2026)
  13. 8.6.3 North America Growth & Differentiation Factor 8 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Growth & Differentiation Factor 8 Revenue (2021-2032)
  2. 9.2 Europe Growth & Differentiation Factor 8 Revenue by Type (2021-2032)
  3. 9.2.1 Europe Growth & Differentiation Factor 8 Revenue by Type (2021-2026)
  4. 9.2.2 Europe Growth & Differentiation Factor 8 Revenue by Type (2027-2032)
  5. 9.3 Europe Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032)
  6. 9.4 Europe Growth & Differentiation Factor 8 Revenue by Application (2021-2032)
  7. 9.4.1 Europe Growth & Differentiation Factor 8 Revenue by Application (2021-2026)
  8. 9.4.2 Europe Growth & Differentiation Factor 8 Revenue by Application (2027-2032)
  9. 9.5 Europe Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032)
  10. 9.6 Europe Growth & Differentiation Factor 8 Revenue by Country
  11. 9.6.1 Europe Growth & Differentiation Factor 8 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Growth & Differentiation Factor 8 Revenue by Country (2021-2026)
  13. 9.6.3 Europe Growth & Differentiation Factor 8 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Growth & Differentiation Factor 8 Revenue (2021-2032)
  2. 10.2 China Growth & Differentiation Factor 8 Revenue by Type (2021-2032)
  3. 10.2.1 China Growth & Differentiation Factor 8 Revenue by Type (2021-2026)
  4. 10.2.2 China Growth & Differentiation Factor 8 Revenue by Type (2027-2032)
  5. 10.3 China Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032)
  6. 10.4 China Growth & Differentiation Factor 8 Revenue by Application (2021-2032)
  7. 10.4.1 China Growth & Differentiation Factor 8 Revenue by Application (2021-2026)
  8. 10.4.2 China Growth & Differentiation Factor 8 Revenue by Application (2027-2032)
  9. 10.5 China Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Growth & Differentiation Factor 8 Revenue (2021-2032)
  2. 11.2 Asia Growth & Differentiation Factor 8 Revenue by Type (2021-2032)
  3. 11.2.1 Asia Growth & Differentiation Factor 8 Revenue by Type (2021-2026)
  4. 11.2.2 Asia Growth & Differentiation Factor 8 Revenue by Type (2027-2032)
  5. 11.3 Asia Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032)
  6. 11.4 Asia Growth & Differentiation Factor 8 Revenue by Application (2021-2032)
  7. 11.4.1 Asia Growth & Differentiation Factor 8 Revenue by Application (2021-2026)
  8. 11.4.2 Asia Growth & Differentiation Factor 8 Revenue by Application (2027-2032)
  9. 11.5 Asia Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032)
  10. 11.6 Asia Growth & Differentiation Factor 8 Revenue by Country
  11. 11.6.1 Asia Growth & Differentiation Factor 8 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Growth & Differentiation Factor 8 Revenue by Country (2021-2026)
  13. 11.6.3 Asia Growth & Differentiation Factor 8 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Growth & Differentiation Factor 8 Revenue (2021-2032)
  2. 12.2 SAMEA Growth & Differentiation Factor 8 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Growth & Differentiation Factor 8 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Growth & Differentiation Factor 8 Revenue by Type (2027-2032)
  5. 12.3 SAMEA Growth & Differentiation Factor 8 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Growth & Differentiation Factor 8 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Growth & Differentiation Factor 8 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Growth & Differentiation Factor 8 Revenue by Application (2027-2032)
  9. 12.5 SAMEA Growth & Differentiation Factor 8 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Growth & Differentiation Factor 8 Revenue by Country
  11. 12.6.1 SAMEA Growth & Differentiation Factor 8 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Growth & Differentiation Factor 8 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Growth & Differentiation Factor 8 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst